梅萨医疗 MLAB 深沪

已收盘 04-02 16:00:00 美东时间

91.08

+2.620

+2.96%

华盛通

立即下载

最高91.325
今开86.58
成交量 9.14万股
最低 86.51
昨收 88.46
总市值 5.03亿
52周最高 130.56
市盈率 ^静 --
换手率 1.65%
52周最低 54.97
委比 -45.95%
总股本 552.48万
历史最高 330.70
量比 0.83
振幅 5.44%
历史最低 25.17
每手 1
风险率 16.42%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Laboratories, Inc. announced a quarterly dividend of $0.16 per share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. The company, a global leader in life science tools and quality control solutions for pharmaceuticals, healthcare, and medical devices, also included forward-looking statements highlighting potential risks and uncertainties that could affect future results.

04-02 22:00
Mesa Laboratories President, CEO Gary Owens Stepping Down, Effective April 12; Siddhartha Kadia Appointed Successor

Mesa Laboratories, Inc. (NASDAQ: MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down

03-10 04:31
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价

今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元

02-05 11:28
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $83 to $94.

02-04 22:54
Earnings Breakdown: Mesa Laboratories Q3

The earnings results for Mesa Laboratories (NASDAQ:MLAB) for Q3 were made publi...

02-03 21:18
Mesa Laboratories Q3 Adj. EPS $3.07, Sales $65.126M Beat $63.359M Estimate

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $3.07 per share this is a 12.87 percent increase over earnings of $2.72 per share from the same period last year. The company reported quarterly sales of

02-03 21:05
Mesa Laboratories Q3 Earnings Summary & Key Takeaways

Mesa Laboratories (NASDAQ:MLAB) just disclosed its Q3 earnings on Tuesday, Febr...

02-03 21:04
MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Laboratories, Inc. announced a regular quarterly dividend of $0.16 per share of common stock, payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026. The company is a global leader in life science tools and critical quality control solutions for the pharmaceutical, healthcare, and medical device industries. Forward-looking statements in this release are subject to risks and uncertainties that could...

01-07 22:00
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元

今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元

2025-12-16 09:36
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $75 to $83.

2025-12-16 02:27

派息除权日	每股总股息	派息日期
2026-02-27	0.16	2026-03-16
2025-11-28	0.16	2025-12-15
2025-08-29	0.16	2025-09-15
2025-05-30	0.16	2025-06-16
2025-02-28	0.16	2025-03-17
2024-11-29	0.16	2024-12-16
2024-08-30	0.16	2024-09-16
2024-05-31	0.16	2024-06-14
2024-02-28	0.16	2024-03-15
2023-11-29	0.16	2023-12-15
2023-08-30	0.16	2023-09-15
2023-05-30	0.16	2023-06-15
2023-02-27	0.16	2023-03-15
2022-11-29	0.16	2022-12-15
2022-08-30	0.16	2022-09-15
2022-05-27	0.16	2022-06-15
2022-02-25	0.16	2022-03-15
2021-11-29	0.16	2021-12-15
2021-08-30	0.16	2021-09-15
2021-05-27	0.16	2021-06-15
2021-02-25	0.16	2021-03-15
2020-11-27	0.16	2020-12-15
2020-08-28	0.16	2020-09-15
2020-05-28	0.16	2020-06-15
2020-02-27	0.16	2020-03-16
2019-11-27	0.16	2019-12-16
2019-08-29	0.16	2019-09-16
2019-05-30	0.16	2019-06-14
2019-02-27	0.16	2019-03-15
2018-11-29	0.16	2018-12-17
2018-08-30	0.16	2018-09-17
2018-05-30	0.16	2018-06-15
2018-02-27	0.16	2018-03-15
2017-11-29	0.16	2017-12-15
2017-08-29	0.16	2017-09-15
2017-05-26	0.16	2017-06-15
2017-02-24	0.16	2017-03-15
2016-11-28	0.16	2016-12-15
2016-08-29	0.16	2016-09-15
2016-05-26	0.16	2016-06-15
2016-02-25	0.16	2016-03-15
2015-11-25	0.16	2015-12-15
2015-08-27	0.16	2015-09-15
2015-05-27	0.16	2015-06-15
2015-02-25	0.16	2015-03-16
2014-11-25	0.16	2014-12-15
2014-08-27	0.15	2014-09-15
2014-05-28	0.15	2014-06-16
2014-02-26	0.15	2014-03-17
2013-11-26	0.15	2013-12-16
2013-08-28	0.14	2013-09-18
2013-05-22	0.14	2013-06-14
2013-02-25	0.14	2013-03-15
2012-11-28	0.14	2012-12-14
2012-08-27	0.13	2012-09-17
2012-05-25	0.13	2012-06-15
2012-02-23	0.13	2012-03-15
2011-11-23	0.13	2011-12-15
2011-08-24	0.12	2011-09-15
2011-05-26	0.12	2011-06-15
2011-02-23	0.12	2011-03-15
2010-11-24	0.12	2010-12-15
2010-08-27	0.11	2010-09-15
2010-05-26	0.11	2010-06-15
2010-02-24	0.11	2010-03-15
2009-11-25	0.11	2009-12-15
2009-08-26	0.10	2009-09-15
2009-05-29	0.10	2009-06-15
2009-02-25	0.10	2009-03-16
2008-11-24	0.10	2008-12-15
2008-08-26	0.10	2008-09-15
2008-05-22	0.10	2008-06-13
2008-02-21	0.10	2008-03-14
2007-11-21	0.10	2007-12-14
2007-08-21	0.08	2007-09-14
2007-05-17	0.08	2007-06-15
2007-02-27	0.08	2007-03-15
2006-11-29	0.18	2006-12-15
2006-08-30	0.07	2006-09-15
2006-05-30	0.07	2006-06-15
2006-02-27	0.07	2006-03-15
2005-11-29	0.32	2005-12-15
2005-08-30	0.06	2005-09-15
2005-05-27	0.06	2005-06-15
2005-02-25	0.06	2005-03-15
2004-11-29	0.26	2004-12-15
2004-08-30	0.05	2004-09-15
2004-05-27	0.05	2004-06-15
2004-02-26	0.05	2004-03-15
2003-11-26	0.20	2003-12-15

公司名称	梅萨医疗
行业分类	电力设备
业务描述	Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

梅萨医疗 MLAB 深 沪

91.08

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

梅萨医疗 MLAB 深沪